Lahu, Shqipdona MD ,,*; Presch, Antonia MD ,*; Ndrepepa, Gjin MD; Menichelli, Maurizio MD; Valina, Christian MD; Hemetsberger, Rayyan MD; Witzenbichler, Bernhard MD; Bernlochner, Isabell MD; Joner, Michael MD; Xhepa, Erion MD, PhD; Hapfelmeier, Alexander MSc; Kufner, Sebastian MD; Rifatov, Nonglag RN; Sager, Hendrik B. MD; Mayer, Katharina MD; Kessler, Thorsten MD; Laugwitz, Karl-Ludwig MD; Richardt, Gert MD; Schunkert, Heribert MD; Neumann, Franz-Josef MD; Sibbing, Dirk MD; Angiolillo, Dominick J. MD; Kastrati, Adnan MD; Cassese, Salvatore MD, PhD
doi : 10.1161/CIRCINTERVENTIONS.122.012204
The relative efficacy and safety of more potent P2Y12 inhibitors in patients with acute coronary syndrome and high bleeding risk (HBR) undergoing percutaneous coronary intervention remains unclear.
Rashid, Muhammad PhD ,,*; Zaman, Mahvash MBChB ,*; Ludman, Peter MD; Wijeysundera, Harindra C. PhD; Curzen, Nick PhD; Kinnaird, Tim MD; Moledina, Saadiq MRCP; Abbott, J. Dawn MD; Grines, Cindy L. MD; Mamas, Mamas A. DPhil
doi : 10.1161/CIRCINTERVENTIONS.122.012037
Nonsurgical centers (NSC) contribute significantly to the capacity of overall percutaneous coronary intervention (PCI) in the United Kingdom. Although previous studies have demonstrated similar PCI outcomes in surgical centers (SC) versus NSC, it is unknown whether this applies to more complex procedures such as left main stem (LMS) PCI.
Cigarroa, Joaquin E. MD
Madder, Ryan D. MD; Seth, Milan MS; Sukul, Devraj MD, MSc; Alraies, M. Chadi MD; Qureshi, Mansoor MD; Tucciarone, Michael MD; Saltiel, Frank MD; Qureshi, M. Imran MD; Gurm, Hitinder S. MD
doi : 10.1161/CIRCINTERVENTIONS.122.012182
Intracoronary imaging (ICI) during percutaneous coronary intervention (PCI) improves outcomes, yet hospital- and physician-level variabilities in ICI and its impact on ICI use in contemporary PCI remain unknown. This study was performed to evaluate hospital- and physician-level use of ICI to optimize PCI.
Killu, Ammar M. MBBS; Collins, Jeremy D. MD; Eleid, Mackram F. MD; Alkhouli, Mohamad MD; Simard, Trevor MD; Rihal, Charanjit MD; Asirvatham, Samuel J. MD; Guerrero, Mayra MD
doi : 10.1161/CIRCINTERVENTIONS.122.012228
Left ventricular outflow tract obstruction may occur following transcatheter mitral valve replacement in the setting of mitral annular calcification.
Butala, Neel M. MD, MBA; Wood, David A. MD; Li, Haiyan MS; Chinnakondepalli, Khaja MS; Lauck, Sandra B. PhD; Sathananthan, Janarthanan MBCHB; Cairns, John A. MD; Magnuson, Elizabeth A. ScD; Barker, Madeleine MD; Webb, John G. MD; Welsh, Robert MD; Cheung, Anson MD; Ye, Jian MD; Velianou, James L. MD; Wijeysundera, Harindra C. MD; Asgar, Anita MD; Kodali, Susheel MD; Thourani, Vinod H. MD; Cohen, David J. MD, MSc; on behalf of the 3M-TAVR Investigators
doi : 10.1161/CIRCINTERVENTIONS.122.012168
The 3M-TAVR trial (3M-Transcatheter Aortic Valve Replacement) demonstrated the feasibility and safety of next-day hospital discharge after transfemoral TAVR with implementation of a minimalist pathway.
Hascoet, Sebastien MD, PhD; Smolka, Grzegorz MD, PhD; Blanchard, David MD; Kloeckner, Martin MD; Brochet, Eric MD; Bouisset, Frederic MD, PhD; Leurent, Guillaume MD, PhD; Thambo, Jean-Benoit MD, PhD; Combes, Nicolas MD; Dumonteil, Nicolas MD; Bauer, Fabrice MD, PhD; Nejjari, Mohammed MD; Pilliere, Remy MD; Dauphin, Claire MD; Bonnet, Guillaume MD; Ciobotaru, Vlad MD, PhD student; Ketelers, Regis MD; Gallet, Romain MD, PhD; Hammoudi, Nadjib MD; Mangin, Lionel MD; Bouvaist, Helene MD; Spaulding, Christian MD, PhD; Aminian, Adel MD; Kilic, Teoman MD; Popovic, Batric MD; Armero, Sebastien MD; Champagnac, Didier MD; Gerardin, Benoit MD
doi : 10.1161/CIRCINTERVENTIONS.122.012193
Transcatheter closure of a symptomatic prosthetic paravalvular leak (PVL) is feasible, but there is presently no conclusive evidence to show consistent efficacy. We aimed to identify predictors of clinical success after transcatheter PVL closure.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟